Hoàng Nhất Minh Nguyễn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hoàng Nhất Minh Nguyễn has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Toan Duong Pham
IVFMD and HOPE Research Center, My Duc Hospital, Ho Chi Minh City, Vietnam
8 shared publications - Lan Ngoc Vuong
Department of Obstetrics and Gynaecology, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam
7 shared publications - Tuong Manh Ho
IVFMD and HOPE Research Center, My Duc Hospital, Ho Chi Minh City, Vietnam
5 shared publications - Nam T. Nguyen
IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam
4 shared publications - Vu Ngoc-Anh Ho
IVFMD and HOPE Research Centre, My Duc Hospital, Ho Chi Minh City, Vietnam
4 shared publications - Bao G. Huynh
IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam
3 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by University of Medicine and Pharmacy at Ho Chi Minh City in MedPharmRes
- Vol. 10 (2) , 216-225
Effect of super-growth differentiation factor-9 (GDF9) during capacitation in vitro maturation of oocytes from small antral follicles: an exploratory pilot study
This pilot study determined the effect of adding Super-growth differentiation factor-9 (GDF9) to capacitation in-vitro maturation (CAPA-IVM) culture media on oocyte maturation and blastocyst formation. The study was conducted at an academic infertility center in Vietnam in January–February 2025. Cumulus-oocyte complexes (COCs) were obtained from consenting subfertile women aged 18–35 years who had polycystic ovary syndrome, ≥30 COCs at oocyte pick-up (OPU) in a CAPA-IVM cycle, and were willing to donate ≥10 COCs for research purposes. COCs from sibling human oocytes were treated without (control) or with Super-GDF9 (50 ng/mL) added to CAPA-IVM capacitation and maturation cultures. All metaphase II (MII) oocytes were inseminated using intracytoplasmic sperm injection. The primary endpoint was proportion of blastocysts at end of culture (per patient/per COCs). For per-patient outcomes, only the median [interquartile range] rate of good-quality blastocysts per total blastocysts differed significantly between the Super-GDF9 (0.0 [0.0, 0.0]) and control (83.3 [16.7, 100.0]) groups (effect size [95% confidence interval] –50.0 [–100.0, 0.0]; p=0.02). There were no good-quality blastocysts in the Super-GDF9 group. The rate of blastocysts (per COCs and per day-3 embryos) tended to be lower in the Super-GDF9 group. Adding Super-GDF9 to the current CAPA-IVM protocol did not improve blastocyst formation and showed a trend toward lower blastocyst formation, which requires confirmation in adequately powered studies.
- 30 June 2026
- Published by University of Medicine and Pharmacy at Ho Chi Minh City in MedPharmRes
- Vol. 10 (2) , 216-225
Open AccessEffect of super-growth differentiation factor-9 (GDF9) during capacitation in vitro maturation of oocytes from small antral follicles: an exploratory pilot study
This pilot study determined the effect of adding Super-growth differentiation factor-9 (GDF9) to capacitation in-vitro maturation (CAPA-IVM) culture media on oocyte maturation and blastocyst formation. The study was conducted at an academic infertility center in Vietnam in January–February 2025. Cumulus-oocyte complexes (COCs) were obtained from consenting subfertile women aged 18–35 years who had polycystic ovary syndrome, ≥30 COCs at oocyte pick-up (OPU) in a CAPA-IVM cycle, and were willing to donate ≥10 COCs for research purposes. COCs from sibling human oocytes were treated without (control) or with Super-GDF9 (50 ng/mL) added to CAPA-IVM capacitation and maturation cultures. All metaphase II (MII) oocytes were inseminated using intracytoplasmic sperm injection. The primary endpoint was proportion of blastocysts at end of culture (per patient/per COCs). For per-patient outcomes, only the median [interquartile range] rate of good-quality blastocysts per total blastocysts differed significantly between the Super-GDF9 (0.0 [0.0, 0.0]) and control (83.3 [16.7, 100.0]) groups (effect size [95% confidence interval] –50.0 [–100.0, 0.0]; p=0.02). There were no good-quality blastocysts in the Super-GDF9 group. The rate of blastocysts (per COCs and per day-3 embryos) tended to be lower in the Super-GDF9 group. Adding Super-GDF9 to the current CAPA-IVM protocol did not improve blastocyst formation and showed a trend toward lower blastocyst formation, which requires confirmation in adequately powered studies.
- Open Access
- 17 February 2026
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2026 (2) , hoag012
Impact of glucose metabolism abnormalities on live birth rate in South-East Asian women with polycystic ovary syndrome
Is there a difference in live birth rates at 24 months between infertile women with polycystic ovary syndrome (PCOS) who have normal versus abnormal glucose metabolism? Abnormal glucose metabolism did not significantly reduce live birth rates but was associated with increased obstetric complications. Women with PCOS are often at increased risk of glucose metabolism disorders. However, evidence about the impact of these disorders on pregnancy outcomes remains limited, particularly in Asian populations. This prospective cohort study was conducted at a reproductive care centre in Vietnam from June 2020 to August 2024. A total of 1208 women were enrolled. Eligible participants were infertile women aged 18–40 years diagnosed with PCOS (Rotterdam criteria). Comprehensive assessments included medical history, anthropometric measurements, endocrine evaluations, fasting plasma glucose (FPG), glycosylated haemoglobin (HbAlc), and oral glucose tolerance tests (OGTT). Participants were categorized into normal or abnormal glucose metabolism groups and monitored for live birth outcomes at 24 months from the first visit. Live birth rates at 24 months were comparable between women with normal versus abnormal glucose metabolism (52.7% vs 48.2%, P = 0.12). However, obstetric complications, including gestational diabetes mellitus (15.2% vs 28.0%, P < 0.001) and hypertensive disorders of pregnancy (2.3% vs 9.0%, P < 0.001), were more common in the group with abnormal glucose metabolism. In women who conceived naturally, greater waist circumference and higher Homeostatic Model Assessment of Insulin Resistance index were significantly associated with lower odds of live birth, whereas the presence of hyperandrogenism was associated with higher odds of live birth. No factors were significantly associated with live birth in the group that conceived via ovulation induction plus IUI. In the group that conceived through IVF or IVM, a higher BMI was significantly associated with a lower live birth rate. This single-centre study was conducted exclusively on infertile women from South-East Asia who had PCOS, potentially limiting generalizability to other populations. Additionally, metabolic assessments were only performed at baseline, preventing evaluation of longitudinal changes and their dynamic effects on reproductive outcomes. While no significant difference in live birth rates was observed between PCOS women with normal and abnormal glucose metabolism, the abnormal glucose metabolism group experienced higher rates of gestational complications. These findings underscore the importance of preconception metabolic screening and tailored fertility strategies that include targeted interventions to optimize reproductive and maternal outcomes in women with PCOS. This study was supported by My Duc Hospital. Lan N. Vuong reports funding from the Vietnam National Foundation for Science and Technology Development (NAFOSTED; grant number FWO.108-2022.01); Merck: Speaker and conference fees; Merck Sharp and Dohme: speaker and conference fees as well as a grant; Ferring: speaker, conference, and scientific board fees outside the submitted work. All other authors declare no conflicts of interest. NCT04364087.
- 17 February 2026
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2026 (2) , hoag012
Open AccessImpact of glucose metabolism abnormalities on live birth rate in South-East Asian women with polycystic ovary syndrome
Is there a difference in live birth rates at 24 months between infertile women with polycystic ovary syndrome (PCOS) who have normal versus abnormal glucose metabolism? Abnormal glucose metabolism did not significantly reduce live birth rates but was associated with increased obstetric complications. Women with PCOS are often at increased risk of glucose metabolism disorders. However, evidence about the impact of these disorders on pregnancy outcomes remains limited, particularly in Asian populations. This prospective cohort study was conducted at a reproductive care centre in Vietnam from June 2020 to August 2024. A total of 1208 women were enrolled. Eligible participants were infertile women aged 18–40 years diagnosed with PCOS (Rotterdam criteria). Comprehensive assessments included medical history, anthropometric measurements, endocrine evaluations, fasting plasma glucose (FPG), glycosylated haemoglobin (HbAlc), and oral glucose tolerance tests (OGTT). Participants were categorized into normal or abnormal glucose metabolism groups and monitored for live birth outcomes at 24 months from the first visit. Live birth rates at 24 months were comparable between women with normal versus abnormal glucose metabolism (52.7% vs 48.2%, P = 0.12). However, obstetric complications, including gestational diabetes mellitus (15.2% vs 28.0%, P < 0.001) and hypertensive disorders of pregnancy (2.3% vs 9.0%, P < 0.001), were more common in the group with abnormal glucose metabolism. In women who conceived naturally, greater waist circumference and higher Homeostatic Model Assessment of Insulin Resistance index were significantly associated with lower odds of live birth, whereas the presence of hyperandrogenism was associated with higher odds of live birth. No factors were significantly associated with live birth in the group that conceived via ovulation induction plus IUI. In the group that conceived through IVF or IVM, a higher BMI was significantly associated with a lower live birth rate. This single-centre study was conducted exclusively on infertile women from South-East Asia who had PCOS, potentially limiting generalizability to other populations. Additionally, metabolic assessments were only performed at baseline, preventing evaluation of longitudinal changes and their dynamic effects on reproductive outcomes. While no significant difference in live birth rates was observed between PCOS women with normal and abnormal glucose metabolism, the abnormal glucose metabolism group experienced higher rates of gestational complications. These findings underscore the importance of preconception metabolic screening and tailored fertility strategies that include targeted interventions to optimize reproductive and maternal outcomes in women with PCOS. This study was supported by My Duc Hospital. Lan N. Vuong reports funding from the Vietnam National Foundation for Science and Technology Development (NAFOSTED; grant number FWO.108-2022.01); Merck: Speaker and conference fees; Merck Sharp and Dohme: speaker and conference fees as well as a grant; Ferring: speaker, conference, and scientific board fees outside the submitted work. All other authors declare no conflicts of interest. NCT04364087.
- Open Access
- 17 December 2025
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 07 (04) , 152-158
Psychomotor Development of Children Born from Couples Undergoing Intracytoplasmic Sperm Injection with Assisted Oocyte Activation
Background: Assisted oocyte activation (AOA) has been used to improve fertilization rates after intracytoplasmic sperm injection (ICSI) by artificially increasing oocyte calcium concentration. However, concerns remain about its potential long-term impact on child development. Limited data exist on developmental outcomes in children born after ICSI with AOA. This study investigated psychomotor development at 12 months of age in children born after ICSI with or without AOA. Methods: This prospective cohort study included 55 children born after frozen embryo transfer: 29 in the AOA group and 26 in the non-AOA group. At 12 months, parents completed the Ages and Stages Questionnaire, Third Edition (ASQ-3), and the Developmental Milestones Red Flags checklist, validated for assessing psychomotor development. Parents also reported their child’s physical characteristics (e.g., height and weight) and medical history, including hospital admissions and chronic illnesses. Outcomes included proportions of children with abnormal ASQ-3 scores, Red Flag signs, and adverse medical/growth outcomes. Results: Baseline parental and perinatal characteristics were comparable between groups. At 12 months, no significant differences were observed in the proportion of children with abnormal ASQ-3 scores across five developmental domains (communication, gross motor, fine motor, personal-social, and problem-solving skills). The prevalence of Red Flag signs and rates of illnesses, hospitalizations, and chronic conditions were also similar. However, children in the non-AOA group were significantly taller than those in the AOA group (77.1 ± 2.2 cm vs. 74.6 ± 4.0 cm; [ ] = 0.02). Conclusions: Children in the AOA group showed similar psychomotor development at 12 months compared to those in the non-AOA group.
- 17 December 2025
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 07 (04) , 152-158
Open AccessPsychomotor Development of Children Born from Couples Undergoing Intracytoplasmic Sperm Injection with Assisted Oocyte Activation
Background: Assisted oocyte activation (AOA) has been used to improve fertilization rates after intracytoplasmic sperm injection (ICSI) by artificially increasing oocyte calcium concentration. However, concerns remain about its potential long-term impact on child development. Limited data exist on developmental outcomes in children born after ICSI with AOA. This study investigated psychomotor development at 12 months of age in children born after ICSI with or without AOA. Methods: This prospective cohort study included 55 children born after frozen embryo transfer: 29 in the AOA group and 26 in the non-AOA group. At 12 months, parents completed the Ages and Stages Questionnaire, Third Edition (ASQ-3), and the Developmental Milestones Red Flags checklist, validated for assessing psychomotor development. Parents also reported their child’s physical characteristics (e.g., height and weight) and medical history, including hospital admissions and chronic illnesses. Outcomes included proportions of children with abnormal ASQ-3 scores, Red Flag signs, and adverse medical/growth outcomes. Results: Baseline parental and perinatal characteristics were comparable between groups. At 12 months, no significant differences were observed in the proportion of children with abnormal ASQ-3 scores across five developmental domains (communication, gross motor, fine motor, personal-social, and problem-solving skills). The prevalence of Red Flag signs and rates of illnesses, hospitalizations, and chronic conditions were also similar. However, children in the non-AOA group were significantly taller than those in the AOA group (77.1 ± 2.2 cm vs. 74.6 ± 4.0 cm; [ ] = 0.02). Conclusions: Children in the AOA group showed similar psychomotor development at 12 months compared to those in the non-AOA group.
- 3 December 2025
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 173 (2) , 1045-1052
Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study
Objective: To evaluate serum magnesium concentrations in pregnant women with severe pre‐eclampsia being treated with a novel magnesium sulfate regimen for seizure prevention. Methods: This was a prospective, longitudinal study. Pregnant women aged 18 years or older with severe pre‐eclampsia and an indication for treatment with magnesium sulfate were included. Participants received a magnesium sulfate loading dose of 4.5 g over 20 min, then a maintenance dose of 1.5 g/h (the standard regimen at the study center). Serum magnesium concentrations were measured at admission, 30 min, 1, 2, 4, and 6 h, then every 6 h until treatment was stopped. Median (interquartile range [IQR]) serum magnesium concentrations are reported. The primary outcome was serum magnesium concentrations during magnesium sulfate infusion. Results: Serum magnesium concentrations at admission and after 30 min were 0.77 (IQR 0.72–0.82) and 1.81 (IQR 1.63–1.97) mmol/L, respectively. After 4 h, the concentration had decreased slightly to 1.79 (IQR 1.58–2.02) mmol/L. By 12 h, magnesium levels had stabilized at 2 mmol/L. At this time, 50.9% (28/55) had achieved therapeutic magnesium levels (2.0–3.5 mmol/L), and this proportion had increased to 61.7% (29/47) by 24 h. Magnesium toxicity was observed in three patients (4.7%). No cases of eclampsia or maternal mortality were recorded. Conclusions: This magnesium sulfate regimen was generally well tolerated and also prevented seizures even though serum magnesium levels at 24 h were below the currently defined therapeutic range in at least one‐third of participants.
- 3 December 2025
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 173 (2) , 1045-1052
Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study
Objective: To evaluate serum magnesium concentrations in pregnant women with severe pre‐eclampsia being treated with a novel magnesium sulfate regimen for seizure prevention. Methods: This was a prospective, longitudinal study. Pregnant women aged 18 years or older with severe pre‐eclampsia and an indication for treatment with magnesium sulfate were included. Participants received a magnesium sulfate loading dose of 4.5 g over 20 min, then a maintenance dose of 1.5 g/h (the standard regimen at the study center). Serum magnesium concentrations were measured at admission, 30 min, 1, 2, 4, and 6 h, then every 6 h until treatment was stopped. Median (interquartile range [IQR]) serum magnesium concentrations are reported. The primary outcome was serum magnesium concentrations during magnesium sulfate infusion. Results: Serum magnesium concentrations at admission and after 30 min were 0.77 (IQR 0.72–0.82) and 1.81 (IQR 1.63–1.97) mmol/L, respectively. After 4 h, the concentration had decreased slightly to 1.79 (IQR 1.58–2.02) mmol/L. By 12 h, magnesium levels had stabilized at 2 mmol/L. At this time, 50.9% (28/55) had achieved therapeutic magnesium levels (2.0–3.5 mmol/L), and this proportion had increased to 61.7% (29/47) by 24 h. Magnesium toxicity was observed in three patients (4.7%). No cases of eclampsia or maternal mortality were recorded. Conclusions: This magnesium sulfate regimen was generally well tolerated and also prevented seizures even though serum magnesium levels at 24 h were below the currently defined therapeutic range in at least one‐third of participants.
- Open Access
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12587
Effect of single versus grouped culture of human cumulus–oocyte complexes in PCOS women treated with biphasic in vitro maturation: A sibling oocyte pilot study
Purpose: This study investigated the differences in the maturation rate of single versus grouped cumulus–oocyte complexes (COCs) culture methods for capacitation in vitro maturation (CAPA‐IVM) in women with polycystic ovary syndrome (PCOS).Methods: This study was performed at My Duc Phu Nhuan Hospital, Vietnam from October 1, 2020 to October 24, 2021. Women aged 18–37 years with a diagnosis of PCOS were recruited. COCs from each woman were randomly divided into two groups: single or grouped culture during CAPA‐IVM culture. The primary outcome was the maturation rate.Results: A total of 322 COCs from 15 eligible women included were randomly assigned to the two study groups. The maturation rate was comparable between the single and grouped culture groups (61.3% vs. 64.8%; p = 0.56). There were no significant differences in the number of 2‐pronuclei fertilized oocytes, number of day‐3 embryos, and number of good‐quality embryos in the two culture method groups. In the single culture group, COCs morphology was associated with the day‐3 embryo formation rate but not the maturation rate.Conclusions: Comparable oocyte maturation and embryology outcomes between single and grouped COCs culture utilizing sibling COCs derived from women with PCOS suggest the feasibility of both methods for CAPA‐IVM culture.
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12587
Open AccessEffect of single versus grouped culture of human cumulus–oocyte complexes in PCOS women treated with biphasic in vitro maturation: A sibling oocyte pilot study
Purpose: This study investigated the differences in the maturation rate of single versus grouped cumulus–oocyte complexes (COCs) culture methods for capacitation in vitro maturation (CAPA‐IVM) in women with polycystic ovary syndrome (PCOS).Methods: This study was performed at My Duc Phu Nhuan Hospital, Vietnam from October 1, 2020 to October 24, 2021. Women aged 18–37 years with a diagnosis of PCOS were recruited. COCs from each woman were randomly divided into two groups: single or grouped culture during CAPA‐IVM culture. The primary outcome was the maturation rate.Results: A total of 322 COCs from 15 eligible women included were randomly assigned to the two study groups. The maturation rate was comparable between the single and grouped culture groups (61.3% vs. 64.8%; p = 0.56). There were no significant differences in the number of 2‐pronuclei fertilized oocytes, number of day‐3 embryos, and number of good‐quality embryos in the two culture method groups. In the single culture group, COCs morphology was associated with the day‐3 embryo formation rate but not the maturation rate.Conclusions: Comparable oocyte maturation and embryology outcomes between single and grouped COCs culture utilizing sibling COCs derived from women with PCOS suggest the feasibility of both methods for CAPA‐IVM culture.
- 12 May 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (10) , 3071-3076
Thyroid Peroxidase Antibodies in Infertile Women with Polycystic Ovary Syndrome
To compare the rate of positive thyroid peroxidase antibodies (TPO Ab) between women with different polycystic ovary syndrome (PCOS) phenotypes and women without PCOS. This is a retrospective cohort study. Women with PCOS at My Duc Hospital between June 1, 2020, and March 27, 2021, were matched with non-PCOS women by age. TPO Ab (cut-off: 34 IU/mL) and thyroid-stimulating hormone (TSH) levels were measured as markers of Hashimoto thyroiditis and thyroid function, respectively. One thousand eight hundred eight infertile women were included, 904 with PCOS (mean age 29.0 ± 3.58 years) and 904 without PCOS (29.1 ± 3.4 years; controls). Women with PCOS had a higher body mass index (22.8 ± 3.84 vs. 19.9 ± 2.23 kg/m2, p < 0.001), but most were not overweight/obese. Rates of positive TPO Ab in women with versus without PCOS were 8.2% and 8.4%, respectively (p = 0.932). Rates of positive TPO Ab in patients with PCOS phenotype A, B, C, or D were not statistically different (7.5%, 2.9%, 20.0%, and 7.8%, respectively). Median TSH concentrations were similar in the PCOS and control groups (1.84 mIU/L vs. 1.78 mIU/L, respectively; p = 0.194). Based on a linear regression model, there was no correlation between either BMI or the estradiol to progesterone ratio and TPO Ab status. In a large population of infertile women with PCOS who were mostly lean patients, rates of positive TPO Ab across all four PCOS phenotypes did not differ significantly from those in women without PCOS. These findings did not support the hypothesis that PCOS is a risk factor for Hashimoto thyroiditis.
- 12 May 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (10) , 3071-3076
Thyroid Peroxidase Antibodies in Infertile Women with Polycystic Ovary Syndrome
To compare the rate of positive thyroid peroxidase antibodies (TPO Ab) between women with different polycystic ovary syndrome (PCOS) phenotypes and women without PCOS. This is a retrospective cohort study. Women with PCOS at My Duc Hospital between June 1, 2020, and March 27, 2021, were matched with non-PCOS women by age. TPO Ab (cut-off: 34 IU/mL) and thyroid-stimulating hormone (TSH) levels were measured as markers of Hashimoto thyroiditis and thyroid function, respectively. One thousand eight hundred eight infertile women were included, 904 with PCOS (mean age 29.0 ± 3.58 years) and 904 without PCOS (29.1 ± 3.4 years; controls). Women with PCOS had a higher body mass index (22.8 ± 3.84 vs. 19.9 ± 2.23 kg/m2, p < 0.001), but most were not overweight/obese. Rates of positive TPO Ab in women with versus without PCOS were 8.2% and 8.4%, respectively (p = 0.932). Rates of positive TPO Ab in patients with PCOS phenotype A, B, C, or D were not statistically different (7.5%, 2.9%, 20.0%, and 7.8%, respectively). Median TSH concentrations were similar in the PCOS and control groups (1.84 mIU/L vs. 1.78 mIU/L, respectively; p = 0.194). Based on a linear regression model, there was no correlation between either BMI or the estradiol to progesterone ratio and TPO Ab status. In a large population of infertile women with PCOS who were mostly lean patients, rates of positive TPO Ab across all four PCOS phenotypes did not differ significantly from those in women without PCOS. These findings did not support the hypothesis that PCOS is a risk factor for Hashimoto thyroiditis.
- Open Access
- 13 April 2023
- Published by Vietnam Association of Obstetrics and Gynecology - VAGO in Tạp chí Phụ sản
- Vol. 20 (2) , 63-69
Tỷ lệ bất thường dung nạp đường ở phụ nữ hiếm muộn người Việt Nam có hội chứng buồng trứng đa nang
Mục tiêu: Khảo sát tỷ lệ bất thường dung nạp đường (IGT) và xác định các yếu tố liên quan với tình trạng IGT ở nhóm phụ nữ hiếm muộn người Việt Nam có hội chứng buồng trứng đa nang (HC BTĐN). Đối tượng và phương pháp nghiên cứu: Phụ nữ hiếm muộn người Việt Nam có HC BTĐN chẩn đoán theo tiêu chuẩn Rotterdam được nhận vào nghiên cứu. Bệnh nhân được khai thác tiền sử, bệnh sử, khảo sát nhân trắc học, siêu âm phụ khoa, xét nghiệm nội tiết, đường huyết đói (FG) và HbA1c. Nếu FG < 125 mg/dL và HbA1c < 6,5%, bệnh nhân được thực hiện xét nghiệm dung nạp glucose đường uống với 75g đường (OGTT). Kết cục chính là tỷ lệ IGT. Dữ liệu được phân tích sử dụng phương pháp thống kê mô tả và mô hình hồi quy logistic đơn, đa biến. Kết quả: Có 903 phụ nữ có HC BTĐN tham gia nghiên cứu từ 6/2020 đến 6/2021. Đa số trẻ tuổi, không thừa cân. 22,6% được chẩn đoán IGT; 3,7% và 5,2% có đái tháo đường (ĐTĐ) típ 2 chẩn đoán bằng FG/HbA1c và OGTT; 68,5% có chuyển hoá đường bình thường. Tình trạng tiền ĐTĐ được phát hiện ở 29,6% bệnh nhân. Tuổi và BMI là hai yếu tố liên quan độc lập của tình trạng IGT sau phân tích hồi quy đa biến. Kết luận: Tỷ lệ IGT và các rối loạn chuyển hoá khác liên quan đường huyết ở phụ nữ hiếm muộn người Việt Nam có HC BTĐN cao, mặc dù cơ địa thừa cân - béo phì là không phổ biến. Objective: To investigate the prevalence of impaired glucose tolerance (IGT) and identify factors associated with IGT status among infertile Vietnamese women with polycystic ovary syndrome (PCOS). Methods: Infertile women with PCOS (Rotterdam criteria) were enrolled. A comprehensive evaluation was performed, including medical history, anthropometric measures, gynecological ultrasound, endocrine tests, fasting glucose (FG), and glycosylated hemoglobin (HbA1c). Women with FG < 125 mg/dL and HbA1c < 6.5% underwent an oral glucose tolerance test (OGTT) with 75 g glucose. The primary outcome was the prevalence of patients with IGT. Data were analyzed using descriptive statistics and univariate and multivariate logistic regression models. Results: Between June 2020 and June 2021, a total number of 903 PCOS women (young, non-obese) participated in the study. 22.6% of women had IGT, 3.7% had T2DM based on FG/HbA1c, 5.2% had T2DM based on 2-hour OGTT, and 68.5% had normal glucose tolerance. Prediabetes was detected in 29.6% of patients. Age and BMI were significantly associated with IGT on multiple regression analysis. Conclusion: The prevalence of IGT and other glucose metabolism abnormalities was high in infertile Vietnamese women with PCOS, even though obesity is not common in this population.
- 13 April 2023
- Published by Vietnam Association of Obstetrics and Gynecology - VAGO in Tạp chí Phụ sản
- Vol. 20 (2) , 63-69
Open AccessTỷ lệ bất thường dung nạp đường ở phụ nữ hiếm muộn người Việt Nam có hội chứng buồng trứng đa nang
Mục tiêu: Khảo sát tỷ lệ bất thường dung nạp đường (IGT) và xác định các yếu tố liên quan với tình trạng IGT ở nhóm phụ nữ hiếm muộn người Việt Nam có hội chứng buồng trứng đa nang (HC BTĐN). Đối tượng và phương pháp nghiên cứu: Phụ nữ hiếm muộn người Việt Nam có HC BTĐN chẩn đoán theo tiêu chuẩn Rotterdam được nhận vào nghiên cứu. Bệnh nhân được khai thác tiền sử, bệnh sử, khảo sát nhân trắc học, siêu âm phụ khoa, xét nghiệm nội tiết, đường huyết đói (FG) và HbA1c. Nếu FG < 125 mg/dL và HbA1c < 6,5%, bệnh nhân được thực hiện xét nghiệm dung nạp glucose đường uống với 75g đường (OGTT). Kết cục chính là tỷ lệ IGT. Dữ liệu được phân tích sử dụng phương pháp thống kê mô tả và mô hình hồi quy logistic đơn, đa biến. Kết quả: Có 903 phụ nữ có HC BTĐN tham gia nghiên cứu từ 6/2020 đến 6/2021. Đa số trẻ tuổi, không thừa cân. 22,6% được chẩn đoán IGT; 3,7% và 5,2% có đái tháo đường (ĐTĐ) típ 2 chẩn đoán bằng FG/HbA1c và OGTT; 68,5% có chuyển hoá đường bình thường. Tình trạng tiền ĐTĐ được phát hiện ở 29,6% bệnh nhân. Tuổi và BMI là hai yếu tố liên quan độc lập của tình trạng IGT sau phân tích hồi quy đa biến. Kết luận: Tỷ lệ IGT và các rối loạn chuyển hoá khác liên quan đường huyết ở phụ nữ hiếm muộn người Việt Nam có HC BTĐN cao, mặc dù cơ địa thừa cân - béo phì là không phổ biến. Objective: To investigate the prevalence of impaired glucose tolerance (IGT) and identify factors associated with IGT status among infertile Vietnamese women with polycystic ovary syndrome (PCOS). Methods: Infertile women with PCOS (Rotterdam criteria) were enrolled. A comprehensive evaluation was performed, including medical history, anthropometric measures, gynecological ultrasound, endocrine tests, fasting glucose (FG), and glycosylated hemoglobin (HbA1c). Women with FG < 125 mg/dL and HbA1c < 6.5% underwent an oral glucose tolerance test (OGTT) with 75 g glucose. The primary outcome was the prevalence of patients with IGT. Data were analyzed using descriptive statistics and univariate and multivariate logistic regression models. Results: Between June 2020 and June 2021, a total number of 903 PCOS women (young, non-obese) participated in the study. 22.6% of women had IGT, 3.7% had T2DM based on FG/HbA1c, 5.2% had T2DM based on 2-hour OGTT, and 68.5% had normal glucose tolerance. Prediabetes was detected in 29.6% of patients. Age and BMI were significantly associated with IGT on multiple regression analysis. Conclusion: The prevalence of IGT and other glucose metabolism abnormalities was high in infertile Vietnamese women with PCOS, even though obesity is not common in this population.
- Open Access
- 11 March 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (5) , 626-634
Development of children born to women with twin pregnancies treated with cervical pessary or vaginal progesterone: Follow‐up of a randomized controlled trial
Introduction: Preterm birth is the most common cause of neonatal morbidity and mortality. Women with twin pregnancies and a short cervical length are at high risk for preterm birth. Vaginal progesterone and cervical pessary have been proposed as potential strategies to reduce preterm birth in this high‐risk population. Therefore, we aimed to compare the effectiveness of cervical pessary and vaginal progesterone in improving developmental outcomes of children born to women with twin pregnancies and mid‐trimester short cervical length.Material and methods: This was a follow‐up study (NCT04295187) of all children at 24 months of age, born from women treated with cervical pessary or progesterone to prevent preterm birth in a randomized controlled trial (NCT02623881). We used a validated Vietnamese version of Ages & Stages Third Edition Questionnaires (ASQ‐3) and a red flag questionnaire. In surviving children, we compared the mean ASQ‐3 scores, abnormal ASQ‐3 scores, the number of children with any abnormal ASQ‐3 scores and red flag signs between the two groups. We reported the composite outcome of perinatal death or survival with any abnormal ASQ‐3 score in offspring. These outcomes were also calculated in a subgroup of women with a cervical length ≤28 mm (P = 0.01). There were no significant differences in the composite outcome of perinatal death or survival with any abnormal ASQ‐3 score in unselected women and in those with cervical length ≤28 mm.Conclusions: Cervical pessary and vaginal progesterone may have comparable effects on developmental outcomes in children at ≥24 months of age, born to women with twin pregnancies and short cervical length. However, this finding could be likely due to a lack of study power.
- 11 March 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (5) , 626-634
Open AccessDevelopment of children born to women with twin pregnancies treated with cervical pessary or vaginal progesterone: Follow‐up of a randomized controlled trial
Introduction: Preterm birth is the most common cause of neonatal morbidity and mortality. Women with twin pregnancies and a short cervical length are at high risk for preterm birth. Vaginal progesterone and cervical pessary have been proposed as potential strategies to reduce preterm birth in this high‐risk population. Therefore, we aimed to compare the effectiveness of cervical pessary and vaginal progesterone in improving developmental outcomes of children born to women with twin pregnancies and mid‐trimester short cervical length.Material and methods: This was a follow‐up study (NCT04295187) of all children at 24 months of age, born from women treated with cervical pessary or progesterone to prevent preterm birth in a randomized controlled trial (NCT02623881). We used a validated Vietnamese version of Ages & Stages Third Edition Questionnaires (ASQ‐3) and a red flag questionnaire. In surviving children, we compared the mean ASQ‐3 scores, abnormal ASQ‐3 scores, the number of children with any abnormal ASQ‐3 scores and red flag signs between the two groups. We reported the composite outcome of perinatal death or survival with any abnormal ASQ‐3 score in offspring. These outcomes were also calculated in a subgroup of women with a cervical length ≤28 mm (P = 0.01). There were no significant differences in the composite outcome of perinatal death or survival with any abnormal ASQ‐3 score in unselected women and in those with cervical length ≤28 mm.Conclusions: Cervical pessary and vaginal progesterone may have comparable effects on developmental outcomes in children at ≥24 months of age, born to women with twin pregnancies and short cervical length. However, this finding could be likely due to a lack of study power.